GSTM 1 polymorphism and cataract risk : a systematic review and a meta-analysis

Yi Zhu,Sicong Wang,Jing Yuan,Dai Li,Xiaojun Cai

2016-01-01

Abstract:Background: Many studies were conducted to assess the relationship between GSTM1 polymorphism and cataract risk. However, results of these studies remained inconclusive. Thus, we performed this systematic review and meta-analysis to clarify the association between GSTM1 polymorphism and cataract risk. Method: PubMed, EMBASE, and Cochrane databases were searched to find relevant studies by two authors. The data were extracted by these two authors independently. The strength of association between the GSTM1 polymorphism and cataract risk was assessed by calculating OR with 95% CI. Results: A total of 16 studies with 3177 cases and 2217controlson the association between GSTM1 polymorphism and cataract risk were included for this meta-analysis. GSTM1 null genotype was associated with a significantly increased risk of cataract (OR=1.44; 95% CI, 1.15-1.80; I2=72%). In the race subgroup analysis, both Asians (OR=1.65; 95% CI, 1.16-2.36; I2=68%) and Caucasians (OR=1.44; 95% CI, 1.09-1.90; I2=69%) with GSTM1 null genotype had increased cataract risk. In the subgroup analysis according to gender, both women and men were not associated with risk of cataract (OR=1.06; 95% CI, 0.88-1.27; I2=0% and OR=0.74; 95% CI, 0.49-1.14; I2=68%, respectively). In the subgroup analysis by cataract type, subjects with GSTM1 null genotype did not show increased cortical cataract risk (OR=0.97; 95% CI, 0.74-1.27; I2=64%), nuclear cataract risk (OR=1.19; 95% CI, 0.93-1.52; I2=22%), and posterior subcapsular cataract risk (OR=1.18; 95% CI, 0.83-1.69; I2=54%). Conclusion: This meta-analysis suggested that GSTM1 null genotype may be associated with the risk of cataract.